On a run to adopt new technologies and implement effective ways which could bring out possible changes in the healthcare industry a lot of innovative techniques have been introduced into the market.
The inventions strongly support patient centricity in spite of all the challenges that may try to take over the industry. Today, companies have started looking at patient participation in a clinical trial as a serious thing which not only generates mere subjects to them but also fetches an overall success of clinical trials through core participation. It then leads to the emergence of the concept called patient-centric trials. A large number of patients are relying on socially available platforms such as technology, social media, and even self-education to entrust medicines which are seen as the crucial part of the industry.
Factors such as financial, social, altruistic or philanthropic could have a greater influence on a patient’s decision to participate in clinical trials. After the incorporation of technology in patient centricity patients have started looking to invest time in learning about the drug mechanism for the cure, the disease of interest and the possible locations where trials can be conducted.
Patients are also keen to know about the results obtained from similar trials with the extensive use of the internet. In order to estimate the safety and effectiveness of a molecule under experimental treatment, a comprehensive clinical trial will be conducted in which clinicians and patients will collaborate with each other along with the respective sponsor to obtain the efficacy of the process.
Feasibility and ease will be given the top priority while conducting the trials by the study by the sponsors. Designing the trial process takes some amount of time. Quite often the techniques followed may lead to a large number of costly and complex trials without addressing the patient’s convenience or needs. By 2018, it is estimated that the medical spending on medicines would increase by 30% ($1.3 trillion).
Digital Patient Space
Digital patient space in patient centricity has the potential to increase the quality of discussions between physicians and patients to a significant level. Benefits incorporating the engagement of digital patients have been realized to a larger extent. Pharmaceutical organizations that are keen on conducting trials-driving cost and efforts saving programs for several contract research organizations (CROs) that offer a ready repository of patients who have enrolled in different trials.
Enhancing Patient Centricity
Patient’s involvement is the key force to enhance patient centricity. It is necessary to track a healthy patient participation right from the initial stages of drug development phases. Competitions or contests will be run on a regular basis by pharmaceuticals to get the inflow of ideas and feedbacks on informed consent forms (ICFs), protocols and trial designs. Based on the responses received out of open discussions on draft protocols that are specifically focused on endpoints, visited structures are encouraged and updates are made accordingly.
Patient engagement is the ultimate key to seeking patient inputs in informed consent forms. To help for this purpose, the Food and Drug Administration (FDA) provides references. Those references could be used to build effective ICFs. Even though some kind of designed approach is used to build ICFs, a science-based approach will facilitate uncover patient insights since the former is behavioral. Innovation solutions across the globe have been sought out by the leading companies that are ready to challenge and support effective crowd sourcing.
Therefore as we have seen the aim of healthcare and its wide established access for the betterment of patient centricity the clinical research centers should have adapted to the growing needs and advancement. In the future, improved healthcare system and profits can be expected if the pharmaceutical industries and patients work symbiotically.